Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, not recruiting

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

NCT01199562

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma

NCT01959698

Conditions: CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Active, not recruiting

Prognostic Model of Elderly Hodgkin Lymphoma in China

NCT07374068

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: Tianjin Cancer Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Active, not recruiting

Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia

NCT04262843

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT03842696

Conditions: Acute Leukemia in Remission, Blast Crisis, Bone Marrow Diseases, +37 more
Locations: University of Colorado Aurora, Colorado, United States

Emory University Atlanta, Georgia, United States

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

University of Michigan Health System Ann Arbor, Michigan, United States

View Trial Details

Active, not recruiting

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

NCT05071209

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +23 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

UCSF Medical Center-Mission Bay San Francisco, California, United States

View all 29 locations

View Trial Details

Active, not recruiting

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

NCT03642626

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Active, not recruiting

Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction

NCT06114498

Conditions: Body Weight, Decompensated Heart Failure, Heart Failure With Preserved Ejection Fraction, +18 more
Locations: Moscow State Clinical Hospital named after V.V. Veresaev Moscow, Russia

National Medical Research Center for Therapy and Preventive Medicine Moscow, Russia

View Trial Details

Active, not recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05023980

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations: California Research Institute Los Angeles, California, United States

Innovative Clinical Research Institute Whittier, California, United States

Oncology-Hematology Associates of West Broward Coral Springs, Florida, United States

New Jersey Center for Cancer Research Brick, New Jersey, United States

View all 108 locations

View Trial Details

Active, not recruiting

Feasibility of [11C]Acetate-PET in LAM and TSC

NCT05467397

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions